Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
ThisCART7 by Suzhou Fundamenta Therapeutics for Non-Hodgkin Lymphoma: Likelihood of Approval
ThisCART7 is under clinical development by Suzhou Fundamenta Therapeutics and currently in Phase I for Non-Hodgkin Lymphoma. According to GlobalData,...
Data Insights
ThisCART7 by Suzhou Fundamenta Therapeutics for Peripheral T-Cell Lymphomas (PTCL): Likelihood of Approval
ThisCART7 is under clinical development by Suzhou Fundamenta Therapeutics and currently in Phase I for Peripheral T-Cell Lymphomas (PTCL). According...